Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Key HighlightsResearchers identified distinct tumor-immune ecologies that differentiate stable disease from progressive disease in non-small cell lung ...

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Scientists at the University of Chicago have built a lipid nanoparticle system that delivers mRNA directly to ...

At Mobile World Congress 2026, TECNO announced an upgrade to its AIoT ecosystem. The update is built around TECNO OneLeap, a new interconnection platform that connects smartphones, tablets, PCs, and ...

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune ...

TECNO OneLeap: A Unified Interconnection Solution for Smarter Ecosystem ...

Online training can contribute to this reconquest by relieving the teacher of the functions of transmission and repetition. The teacher retains the functions of animation, discussion, stimulation and ...

Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

KENNEDY SPACE CENTER — SpaceX’s Falcon 9 rocket pierced the Wednesday morning sky as it launched three spacecraft from NASA and NOAA that will study the solar system’s “bubble,” collect information on ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy.